OAC
OMERS Administration Corp Portfolio holdings
AUM
$12.7B
1-Year Return
22.78%
This Quarter Return
+10.44%
1 Year Return
+22.78%
3 Year Return
+71.29%
5 Year Return
+144.31%
10 Year Return
+293.75%
AUM
$8.74B
AUM Growth
+$821M
(+10%)
Cap. Flow
+$229M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
529
New
236
Increased
28
Reduced
28
Closed
80
Top Buys
| 1 |
Waste Connections
WCN
|
$191M |
| 2 |
Lowe's Companies
LOW
|
$104M |
| 3 |
Broadcom
AVGO
|
$62.4M |
| 4 |
iShares Select Dividend ETF
DVY
|
$44.2M |
| 5 |
ERF
Enerplus Corporation
ERF
|
$34.6M |
Top Sells
| 1 |
Waste Management
WM
|
$161M |
| 2 |
TC Energy
TRP
|
$98.8M |
| 3 |
Yum China
YUMC
|
$19M |
| 4 |
GitLab
GTLB
|
$17.3M |
| 5 |
Microsoft
MSFT
|
$14.5M |
Sector Composition
| 1 | Technology | 21.18% |
| 2 | Financials | 19.07% |
| 3 | Industrials | 11.77% |
| 4 | Healthcare | 9.62% |
| 5 | Energy | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Alto Ingredients
ALTO
$90.6M
| $125K | ﹤0.01% |
+57,200
| New | +$125K |
|
302
Ceragon Networks
CRNT
$180M
| $124K | ﹤0.01% |
+38,600
| New | +$124K |
|
303
Pediatrix Medical
MD
$1.49B
| $123K | ﹤0.01% |
+12,300
| New | +$123K |
|
304
Capricor Therapeutics
CAPR
$308M
| $122K | ﹤0.01% |
+18,000
| New | +$122K |
|
305
Virco
VIRC
$139M
| $120K | ﹤0.01% |
+11,000
| New | +$120K |
|
306
Rekor Systems
REKR
$138M
| $120K | ﹤0.01% |
+52,200
| New | +$120K |
|
307
ASP Isotopes
ASPI
$754M
| $119K | ﹤0.01% |
+28,800
| New | +$119K |
|
308
Telos
TLS
$456M
| $116K | ﹤0.01% |
+28,000
| New | +$116K |
|
309
Stereotaxis
STXS
$264M
| $115K | ﹤0.01% |
+43,900
| New | +$115K |
|
310
TScan Therapeutics
TCRX
$108M
| $113K | ﹤0.01% |
+14,200
| New | +$113K |
|
311
Solarmax Technology
SMXT
$61.9M
| $112K | ﹤0.01% |
+12,200
| New | +$112K |
|
312
Everspin Technologies
MRAM
$147M
| $111K | ﹤0.01% |
+14,000
| New | +$111K |
|
313
Ocugen
OCGN
$322M
| $111K | ﹤0.01% |
+67,400
| New | +$111K |
|
314
Orion Group Holdings
ORN
$301M
| $110K | ﹤0.01% |
+13,400
| New | +$110K |
|
315
Black Diamond Therapeutics
BDTX
$167M
| $107K | ﹤0.01% |
+21,200
| New | +$107K |
|
|
STKL
316
SunOpta
STKL
$779M
| $102K | ﹤0.01% |
+14,800
| New | +$102K |
|
317
Standard BioTools
LAB
$497M
| $101K | ﹤0.01% |
+37,400
| New | +$101K |
|
318
Fulcrum Therapeutics
FULC
$414M
| $100K | ﹤0.01% |
+10,600
| New | +$100K |
|
319
Acumen Pharmaceuticals
ABOS
$87.2M
| $96.4K | ﹤0.01% |
+23,800
| New | +$96.4K |
|
320
Lantronix
LTRX
$185M
| $95.8K | ﹤0.01% |
+26,900
| New | +$95.8K |
|
321
Pixelworks
PXLW
$46.2M
| $92.4K | ﹤0.01% |
+2,983
| New | +$92.4K |
|
322
Blend Labs
BLND
$1.05B
| $92.3K | ﹤0.01% |
+28,400
| New | +$92.3K |
|
|
QVCGA
323
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $92K | ﹤0.01% |
+1,496
| New | +$92K |
|
|
CBIO
324
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $91.8K | ﹤0.01% |
+306
| New | +$91.8K |
|
|
VXRT
325
DELISTED
Vaxart
VXRT
| $91.5K | ﹤0.01% |
+70,400
| New | +$91.5K |
|